Tejnaksh Health.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE030T01027
  • NSEID:
  • BSEID: 539428
INR
15.00
-0.09 (-0.6%)
BSENSE

Jun 18

BSE+NSE Vol: 11.1 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 999962,
    "name": "Tejnaksh Health.",
    "stock_name": "Tejnaksh Health.",
    "full_name": "Tejnaksh Healthcare Ltd",
    "name_url": "stocks-analysis/tejnaksh-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "15.00",
    "chg": -0.09,
    "chgp": "-0.6%",
    "dir": -1,
    "prev_price": "15.09",
    "mcapval": "30.47 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539428,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE030T01027",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "11.1 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/tejnaksh-health-999962-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tejnaksh Healthcare Gains 2.99%: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-gains-299-2-key-factors-driving-the-week-3962464",
        "imagepath": "",
        "date": "2026-04-25 13:05:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 20:</strong> Stock opens at Rs.15.40, gaining 2.26% as Sensex dips marginally</p>\n                    <p><strong>Apr 21:</strong> Continued gains to Rs.15.62 (+1.43%) alongside Sensex rally</p>\n                    <p><strong>Apr 22:</strong> Sharp decline to Rs.15.03 (-3.78%) following downgrade announcement</p>\n                    <p><strong>Apr 23:</strong> Recovery to Rs.15.47 (+2.93%) despite negative market trend</p>\n                    <p><strong>Apr 24:</strong> Slight gain to Rs.15.51 (+0.26%) as week closes</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"s..."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Valuation Shifts Signal Mixed Investor Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-valuation-shifts-signal-mixed-investor-sentiment-3958343",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TejnakshHealthc_valuationdot_3958343.png",
        "date": "2026-04-23 08:01:24",
        "description": "Tejnaksh Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions amid mixed financial metrics and sector comparisons. Despite a recent downgrade in its overall Mojo Grade to Strong Sell, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a nuanced picture of price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Falls 11.62% Amid Fresh 52-Week Lows and Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-falls-1162-amid-fresh-52-week-lows-and-downgrade-3921764",
        "imagepath": "",
        "date": "2026-03-28 13:01:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Stock hits 52-week low at Rs.11.25 amid continued downtrend</p>\n                    <p><strong>23 Mar:</strong> Downgrade to Strong Sell by MarketsMOJO citing weak fundamentals and bearish technicals</p>\n                    <p><strong>27 Mar:</strong> New 52-week low recorded at Rs.10.65, extending losses</p>\n                    <p><strong>27 Mar:</strong> Week closes at Rs.11.18, down 11.62%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</di..."
      }
    ],
    "total": 8,
    "sid": "999962",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/tejnaksh-healthcare-999962"
  },
  "announcements": [
    {
      "caption": "Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026.",
      "datetime": "30-May-2026",
      "details": "Please find enclosed Audited financial results for March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.",
      "datetime": "30-May-2026",
      "details": "1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31 2026 and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations 2015 regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1 2026 and ending on March 31 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue in view of the postponement of the Companys expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015",
      "datetime": "20-May-2026",
      "details": "Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday May 30 2026 400060 to transact the business as given below: 1. To consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31 2026. 2. To transact any other matter with the permission of the Chair. Further in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation 2015 and in compliance of the circular no. LIST/COMP/ 01/2019-20 issued by BSE Limited on 02nd April 2019 intimation for the closure of trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 27th March 2026 till expiry of 48 hours after the declaration of audited financial results of the Company for the quarter and year ended 31st March 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>5:10</strong> stock split, ex-date: 19 Jul 23",
          "dt": "2023-07-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>36:10</strong> bonus issue, ex-date: 26 Apr 18",
          "dt": "2018-04-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026.

30-May-2026 | Source : BSE

Please find enclosed Audited financial results for March 2026

Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.

30-May-2026 | Source : BSE

1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31 2026 and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations 2015 regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1 2026 and ending on March 31 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue in view of the postponement of the Companys expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.

Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015

20-May-2026 | Source : BSE

Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday May 30 2026 400060 to transact the business as given below: 1. To consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31 2026. 2. To transact any other matter with the permission of the Chair. Further in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation 2015 and in compliance of the circular no. LIST/COMP/ 01/2019-20 issued by BSE Limited on 02nd April 2019 intimation for the closure of trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 27th March 2026 till expiry of 48 hours after the declaration of audited financial results of the Company for the quarter and year ended 31st March 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Tejnaksh Healthcare Ltd has announced 5:10 stock split, ex-date: 19 Jul 23

stock-summary
BONUS

Tejnaksh Healthcare Ltd has announced 36:10 bonus issue, ex-date: 26 Apr 18

stock-summary
RIGHTS

No Rights history available